Evidence map›Paper›PMID 27283888›Full record

ArticleScientific reports2016

Down-regulated and Commonly mutated ALPK1 in Lung and Colorectal Cancers.

Hsien-Feng Liao, Hsien-Hsiung Lee, Ya-Sian Chang, Chia-Li Lin, Ting-Yuan Liu, Yu-Chia Chen, Ju-Chen Yen, Ya-Ting Lee, Chien-Yu Lin, Shih-Hsiung Wu and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Hsien-Feng LiaoThe Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.
Hsien-Hsiung LeeEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Ya-Sian ChangEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Chia-Li LinEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Ting-Yuan LiuEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Yu-Chia ChenEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Ju-Chen YenEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Ya-Ting LeeEpigenome Research Center, China Medical University Hospital, Taichung, Taiwan.
Chien-Yu LinDepartment of Laboratory Medicine, China Medical University Hospital, Taichung, Taiwan.
Shih-Hsiung WuThe Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.
Ying-Chin KoEnvironment-Omics-Disease Research Centre, China Medical University Hospital, Taichung, Taiwan.
Jan-Gowth ChangThe Ph.D. Program for Cancer Biology and Drug Discovery, China Medical University and Academia Sinica, Taichung, Taiwan.
China Medical University · TWChina Medical University Hospital · TWInstitute of Biological Chemistry, Academia Sinica · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ALPK1 gene located in the 4q25 region encodes a newly explored protein kinase which could phosphorylate the amino acid of a domain full of α-helices. Recently, several studies have indicated that the expression of ALPK1 is related to inflammation and various diseases; therefore, the purpose of this investigation was to determine whether the expression of ALPK1 has an influence on tumorigenesis and to further scrutinize its gene polymorphism in order to better understand its clinical importance. In lung and colorectal cancer tissues, the ALPK1 RNA level of the normal part was higher than that of the tumor part using the RT-qPCR analysis. Moreover, differences in HRM melting curves could effectively separate the known mutation sites and be used to identify the two novel variants that might cause the bio-dysfunctions of ALPK1 found in silico predictions. Additionally, in both Lovo colorectal and A549 lung cancer cells with enhanced and depleted expression of ALPK1, the encoded ALPK1 could exert its activity on cell migration without interfering with cell viability. Taken together, these findings suggested that ALPK1 might play a vital role in cancer development and that the newly explored SNPs are found in a Taiwanese cohort.

Indexed as

A549 CellsCell Line, TumorCell MovementCell SurvivalCell Transformation, NeoplasticColorectal NeoplasmsDown-RegulationGene Knockdown TechniquesHumansInflammationLung NeoplasmsPolymorphism, Single NucleotideProtein KinasesRNA, MessengerTaiwanALPK1 protein, humanProtein KinasesRNA, Messenger

Identifiers

PMID27283888
PMCPMC4901299
OpenAlexW2419488572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.